168 related articles for article (PubMed ID: 37921212)
1. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Banjare L
Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
[TBL] [Abstract][Full Text] [Related]
2. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
4. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.
Doiron J; Soultan AH; Richard R; Touré MM; Picot N; Richard R; Cuperlović-Culf M; Robichaud GA; Touaibia M
Eur J Med Chem; 2011 Sep; 46(9):4010-24. PubMed ID: 21703734
[TBL] [Abstract][Full Text] [Related]
9. New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity.
Maghraby MT; Mazyad Almutairi T; Bräse S; Salem OIA; Youssif BGM; Sheha MM
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894571
[TBL] [Abstract][Full Text] [Related]
10. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.
Chamduang C; Pingaew R; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2019 Dec; 93():103327. PubMed ID: 31614285
[TBL] [Abstract][Full Text] [Related]
11. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
[TBL] [Abstract][Full Text] [Related]
13. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors.
Banjare L; Singh Y; Verma SK; Singh AK; Kumar P; Kumar S; Jain AK; Thareja S
J Biomol Struct Dyn; 2023 Mar; 41(4):1322-1341. PubMed ID: 34963408
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives.
Song Z; Liu Y; Dai Z; Liu W; Zhao K; Zhang T; Hu Y; Zhang X; Dai Y
Bioorg Med Chem; 2016 Oct; 24(19):4723-4730. PubMed ID: 27567077
[TBL] [Abstract][Full Text] [Related]
16.
Shah U; Patel S; Patel M; Jain N; Pandey N; Chauhan A; Patel A; Patel S
Anticancer Agents Med Chem; 2022; 22(7):1370-1385. PubMed ID: 34455966
[TBL] [Abstract][Full Text] [Related]
17. Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Diaz de Greñu B; Fernández-Aroca DM; Organero JA; Durá G; Jalón FA; Sánchez-Prieto R; Ruiz-Hidalgo MJ; Rodríguez AM; Santos L; Albasanz JL; Manzano BR
J Biol Inorg Chem; 2023 Sep; 28(6):531-547. PubMed ID: 37458856
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of New Pyrimidine-Triazole Derivatives and Investigation of Their Anticancer Activities.
Osmaniye D; Hıdır A; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Chem Biodivers; 2022 Aug; 19(8):e202200216. PubMed ID: 35699405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]